Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T40556 | Target Info | |||
Target Name | Bromodomain-containing protein 4 (BRD4) | ||||
Synonyms | Protein HUNK1; HUNK1 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BRD4 | ||||
Biochemical Class | Bromodomain | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 4-[2-(2,4-difluorophenoxy)-5-(methylsulfonyl)phenyl]-N-ethyl-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide | Ligand Info | |||
Canonical SMILES | CCNC(=O)C1=CC2=C(N1)C(=O)N(C=C2C3=C(C=CC(=C3)S(=O)(=O)C)OC4=C(C=C(C=C4)F)F)C | ||||
InChI | 1S/C24H21F2N3O5S/c1-4-27-23(30)19-11-16-17(12-29(2)24(31)22(16)28-19)15-10-14(35(3,32)33)6-8-20(15)34-21-7-5-13(25)9-18(21)26/h5-12,28H,4H2,1-3H3,(H,27,30) | ||||
InChIKey | GLPRVXBSUHOVMP-UHFFFAOYSA-N | ||||
PubChem Compound ID | 89657560 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6VIW BRD4_Bromodomain1 complex with pyrrolopyridone compound 18 | ||||||
Method | X-ray diffraction | Resolution | 2.43 Å | Mutation | No | [1] |
PDB Sequence |
TNQLQYLLRV
69 VLKTLWKHQF79 AWPFQQPVDA89 VKLNLPDYYK99 IIKTPMDMGT109 IKKRLENNYY 119 WNAQECIQDF129 NTMFTNCYIY139 NKPGDDIVLM149 AEALEKLFLQ159 KINELP |
|||||
|
||||||
PDB ID: 6VIX BRD4_Bromodomain2 complex with pyrrolopyridone compound 18 | ||||||
Method | X-ray diffraction | Resolution | 2.12 Å | Mutation | No | [1] |
PDB Sequence |
HMEQLKCCSG
359 ILKEMFAKKH369 AAYAWPFYKP379 VDVEALGLHD389 YCDIIKHPMD399 MSTIKSKLEA 409 REYRDAQEFG419 ADVRLMFSNC429 YKYNPPDHEV439 VAMARKLQDV449 FEMRFAK |
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain. J Med Chem. 2020 May 28;63(10):5585-5623. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.